Researchers at MIT have developed a noninvasive medical monitoring device powerful enough to detect single cells within blood ...

"When the first BTK inhibitor got approved by the FDA for other conditions, we all saw that follicular lymphoma should be the ...

Cutaneous T-cell lymphoma (CTCL) is a chronic ... top), lumbosacral area (B, top), and right posterior shoulder (C, left) before and 2 months after (A, bottom; B, bottom; and C, right) 8 weeks ...

Researchers at MIT have developed a noninvasive medical monitoring device powerful enough to detect single cells within blood ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Marly, who was suffering from night sweats and itchy skin in early 2024, asked ChatGPT about her symptoms. The AI tool suggested blood cancer, which was later discovered by doctor.

Some of these cancerous mutations in DNA are inherited, while others arise from errors that occur as a cell divides.

The trial will test MB-105 in up to 46 patients with relapsed or refractory CD5-positive cutaneous T-cell lymphoma or peripheral T-cell lymphoma.

FORMER Manchester United starlet Joe Thompson has died at the age of 36. The Bath-born midfielder had been diagnosed with ...

Apr. 15, 2025 — Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence ... of immune cell known as B cells, could be the key to boosting ...

Diffuse large B-cell lymphoma (DLBCL) is the most common and fast-growing type of non-Hodgkin lymphoma, a cancer that affects ...

MB-105, a CD5-targeted CAR-T cell ... lymphoma who currently face extremely limited therapeutic choices,” said Sarah Hein, co-founder and CEO of March Biosciences, in the news release. “CAR-T ...